Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01641900 · ClinicalTrials.gov registry record · NA
Effects of Eszopiclone on Sleep and Memory in Schizophrenia
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 59
- Enrollment target
NCT01641900: Completed NA study, sponsored by Massachusetts General Hospital.
NCT01641900 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 59 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01641900, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
Study Summary
The investigators will test the hypothesis that the sleep medication, eszopiclone, can normalize brain activity during sleep and improve memory in patients with schizophrenia. The investigators will do this by measuring sleep and memory performance on two conditions separated by one week: taking 3 mg of eszopiclone and taking placebo. The investigators will study healthy subjects and chronic, medicated outpatients with schizophrenia.
Interventions
- DRUG placebo
- DRUG eszopiclone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2012-07 |
| Est. Completion | 2015-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01641900
The ClinicalTrials.gov registry entry for NCT01641900 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT01641900 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01641900 about?
NCT01641900 is a clinical study titled "Effects of Eszopiclone on Sleep and Memory in Schizophrenia". The investigators will test the hypothesis that the sleep medication, eszopiclone, can normalize brain activity during sleep and improve memory in patients with schizophrenia. The investigators will do this by measuring sleep and memory performance on two conditions separated by one week: taking 3 m...
What is the current status of trial NCT01641900?
This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2012-07. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01641900?
The interventions under investigation include: placebo (DRUG), eszopiclone (DRUG).
Who is sponsoring clinical trial NCT01641900?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.